@article{74c6aa7f8aa84969a7ab14c2326419dd,
title = "Pemphigus risk following programmed death receptor-1, programmed death ligand-1, or cytotoxic T-lymphocyte-associated protein 4 inhibitors: A 1:1 propensity-matched, global, retrospective cohort study",
keywords = "CTLA-4 inhibitor, PD-1 inhibitor, PD-1L inhibitor, TriNetX, autoimmunity, bullous disease, exposome, immune checkpoint inhibitor, immune-related adverse events (irAEs), pemphigus, trigger",
author = "Justin Baroukhian and Kristina Seiffert-Sinha and Sinha, \{Animesh A.\}",
year = "2025",
month = apr,
doi = "10.1016/j.jdin.2025.01.004",
language = "English",
volume = "19",
pages = "45--47",
journal = "JAAD International",
issn = "2666-3287",
publisher = "Elsevier B.V.",
}